e learning mycobacteria 15.pdf

Upload: anonymous-91vyyeka3i

Post on 03-Mar-2018

220 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/26/2019 E learning mycobacteria 15.pdf

    1/49

    Mycobacteria

  • 7/26/2019 E learning mycobacteria 15.pdf

    2/49

    Introduction

    Order: Actinomycetales

    Family: Mycobacteriaceae

    Genus: Mycobacterium

    > 100 species

  • 7/26/2019 E learning mycobacteria 15.pdf

    3/49

  • 7/26/2019 E learning mycobacteria 15.pdf

    4/49

    Classification

    1. Mycobacteriumtuberculosis

    complex(MTBC)

    M.tuberculosis

    M.bovis

    M.africanum

    M.pinnnipedii

    M.microti

    M.caprae

    M.canettii

    2. Mycobacterium le3. Atypical mycobact

    M.avium avium

    M.avium intracel

    M. kansasiiM. fortuitum

    M. chelonae

    M.abscessus

  • 7/26/2019 E learning mycobacteria 15.pdf

    5/49

  • 7/26/2019 E learning mycobacteria 15.pdf

    6/49

    General characteristics

    Cell wall rich in lipids(mycolic acids)- comprise 60% owall weight

    Slow growers: > 7 days to form colonies

    Acid-fast: do not decolourise in acid and alcohol

  • 7/26/2019 E learning mycobacteria 15.pdf

    7/49

    Virulence factors

    Virulence attributed to ability to survive within macr

  • 7/26/2019 E learning mycobacteria 15.pdf

    8/49

    Mycobacteriumtuberculosis

  • 7/26/2019 E learning mycobacteria 15.pdf

    9/49

    Epidemiology

    In 2013, 9M infected, 1.5M deaths- 360,000 HIV-pos Leading killer of HIV-positive individuals- of all HIV

    deaths

    480,000 developed MDR-TB

    2 billion latently Mtb-infected(LTBI) reservoirs The 2015 MDG of halting and reversing TB incidence

    been achieved

    Kenya among 22 high burden countries

  • 7/26/2019 E learning mycobacteria 15.pdf

    10/49

    Modes of transmission

    Droplet infection Person to person by inhalation aerosols

    Mycobacterium tuberculosis (Pulmonary tuberculosis

    Ingestion of milk

    Infected cattle

    Mycobacterium bovis (Intestinal tuberculosis)

    Contamination of abrasions

    Laboratory workers (Skin infection)

  • 7/26/2019 E learning mycobacteria 15.pdf

    11/49

    Pathogenesis

    Penetrate the alveoli Phagocytosis by resident alveolar macrophages & de

    cells

    Prevent fusion of the phagosome with lysosomes

    Alveolar macrophages produce cytokines and chem Circulating macrophages and lymphocytes are attra

    infectious focus

  • 7/26/2019 E learning mycobacteria 15.pdf

    12/49

    Pathogenesis

    Macrophages may fuse to form multinucleated giancells(MGCs=Langhans cells)

    May also differentiate to form lipid-rich foamy macr

    Results in granuloma formation

    Infected macrophages can also spread to local lymphblood

    Subsequent spread to other tissues, BM, spleen, kid

  • 7/26/2019 E learning mycobacteria 15.pdf

    13/49

  • 7/26/2019 E learning mycobacteria 15.pdf

    14/49

  • 7/26/2019 E learning mycobacteria 15.pdf

    15/49

    Pathogenesis

    1. Primary infection 10% of immune competent individuals

    Bacilli grow unimpeded in host macrophages

    2. Latent infection

    90% of immune competent individuals

    Controlled bacillary growth

    Bacilli either killed or survive within cellular granua non-replicating state

    Can persist for decades

  • 7/26/2019 E learning mycobacteria 15.pdf

    16/49

    Pathogenesis

    3. Post-primary infection May develop directly from a primary lesion= progres

    primary tuberculosis

    OR

    Endogenous reactivation of latent infectionOR

    Infection or exogenous reinfection

  • 7/26/2019 E learning mycobacteria 15.pdf

    17/49

    Pathogenesis

    Post-primary lesions often develop in the upper regi Immune-mediated control of bacillary growth fails

    Tuberculoma formation- granuloma formation but wtissue destruction and caseation

    Liquefication of caseous material Erosion into a bronchus

  • 7/26/2019 E learning mycobacteria 15.pdf

    18/49

    Pathogenesis

    Cavity is formed= characteristic feature of post-primpulmonary TB

    *Granuloma formation= central event in the immunresponse against M.tb

    Spread of bacilli from cavities

    Though bronchus- other areas of the lung, trache

    Swallowed-intestinal tract, anal fistulas

    Through bloodstream to other organs

  • 7/26/2019 E learning mycobacteria 15.pdf

    19/49

    Factors affecting susceptibility to

    Age Immune status

    Medical conditions

    Genetic factors e.g. HLA-DR allele

    Environmental factors- exposure to populations ofenvironmental mycobacteria

    Mycobacterial factors- strain variation in virulence

  • 7/26/2019 E learning mycobacteria 15.pdf

    20/49

    Clinical manifestations

    Weight loss 10% PTB

    Low grade fever, malaise, night sweats, chest paincough(>2 weeks), haemoptysis

    EPTB

    Depends on the site: skeletal, genital tract, urinarCNS, GIT, adrenal, cardiac

  • 7/26/2019 E learning mycobacteria 15.pdf

    21/49

    Laboratory diagnosis

    Specimen:sputum, gastric washings, urine, aspiratespathological material, etc

    Staining of specimen using

    Ziehl Neelsen (ZN) stainacid-fast bacilli (AFBs)-bacilli on a blue or green background

    Kinyoun staining

    Fluorescence stains -auramine O or rhodamine stfluorescent microscopy

  • 7/26/2019 E learning mycobacteria 15.pdf

    22/49

  • 7/26/2019 E learning mycobacteria 15.pdf

    23/49

  • 7/26/2019 E learning mycobacteria 15.pdf

    24/49

    Laboratory diagnosis

    Culture Gold standard in TB diagnosis Require incubation for 6 8 weeks before declari

    negative

    Solid culture (Lowenstein Jensen(LJ), Middlebroo& 7H11

    Liquid culture -Middlebrook 7H12, Bactec, MGITmycobacterial growth indicator tube

  • 7/26/2019 E learning mycobacteria 15.pdf

    25/49

    Laboratory diagnosis

    To confirm M.tuberculosis from culture: Slow growth

    Colonial morphology

    Nitrate reductase test positive

    Niacin test positive

  • 7/26/2019 E learning mycobacteria 15.pdf

    26/49

  • 7/26/2019 E learning mycobacteria 15.pdf

    27/49

  • 7/26/2019 E learning mycobacteria 15.pdf

    28/49

    Laboratory diagnosis

    Molecular techniques

    PCR from culture; some direct from sputum

    Immunological tests

    Tuberculin skin test does not distinguish betweevaccination and disease. Usually negative in patie

    advanced AIDS QuantiFERON , T-SPOT TB Detect interferon . F

    & latent TB

  • 7/26/2019 E learning mycobacteria 15.pdf

    29/49

    Tuberculin skin test

  • 7/26/2019 E learning mycobacteria 15.pdf

    30/49

    reatment

    1

    st

    line: isoniazid,

    rifampicin/ rifabutin,

    ethambutol,

    pyrazinamide, streptomycin

    2nd line:

    para-amino salicy

    cycloserine,

    fluoroquinolone(ofloxacin/ ciprof

    levofloxacin/ etc) amikacin,

    kanamycin,

    capreomycin,

    ethionamide

  • 7/26/2019 E learning mycobacteria 15.pdf

    31/49

    Drug resistance

    Multidrug resistant TB (MDR TB):

    resistant to at least rifampicin & isoniazid

    Extensively drug resistant TB (XDR TB):

    MDR strains that are also resistant to a fluoroquiand at least one second-line injectable agent (amkanamycin or capreomycin)

  • 7/26/2019 E learning mycobacteria 15.pdf

    32/49

    ontrol

    Prompt detection of cases & effective Rx

    Isolation of cases on Rx until non-infectious

    Follow up contacts of cases

    Reducing overcrowding

    Vaccination with BCGvariable results contraindicated in patients with AIDS

  • 7/26/2019 E learning mycobacteria 15.pdf

    33/49

    Mycobacteriumleprae

  • 7/26/2019 E learning mycobacteria 15.pdf

    34/49

    Introduction

    Obligate intracellular organism- can grow in the moor in the armadillo

    =Hansens bacilli

    Reservoir- infected humans, low infectivity

    Transmission- skin to skin contact, respiratory route

    Incubation: 3 5 years, can be as long as 30 years

    Bacilli resemble tuberculous bacilli but are not so stracid fast

  • 7/26/2019 E learning mycobacteria 15.pdf

    35/49

    Pathogenesis

    Principal target is the schwann cell

    Resulting nerve damage is responsible for the anaesand muscle paralysis

    Repeated injuries lead to gradual destruction of ext

    Infiltration of skin and cutaneous nerves leads to forof visible lesions with pigmentary changes

  • 7/26/2019 E learning mycobacteria 15.pdf

    36/49

    Clinical manifestations

    Depends on patients immune reaction

    Ranges from tuberculoid to lepromatous form

    1. Tuberculoid leprosy(Paucibacillary)

    Strong cellular immune reaction but a weak humoral res

    Infected tissues- mainly lymphocytes and granulomas, re

    few bacilli

    2. Lepromatous leprosy(multibacillary)

    Strong antibody response but a specific defect in the maand Schwann cells

  • 7/26/2019 E learning mycobacteria 15.pdf

    37/49

    Clinical manifestations

    1. Intermediate forms

    Borderline tuberculoid(BT)

    Mid-borderline(BB)

    Borderline lepromatous(BL)

  • 7/26/2019 E learning mycobacteria 15.pdf

    38/49

    Tuberculoid leprosy

    http://upload.wikimedia.org/wikipedia/commons/e/e2/Leprosy_thigh_demarcated_cutaneous_lesions.jpghttp://upload.wikimedia.org/wikipedia/commons/e/e2/Leprosy_thigh_demarcated_cutaneous_lesions.jpg
  • 7/26/2019 E learning mycobacteria 15.pdf

    39/49

    Lepromatous leprosy

  • 7/26/2019 E learning mycobacteria 15.pdf

    40/49

    Laboratory diagnosis

    Does not grow in cell-free cultures therefore histopafindings

    Detection of acid fast bacilli in nasal discharges, scrafrom the nasal mucosa

    PCR

  • 7/26/2019 E learning mycobacteria 15.pdf

    41/49

    Treatment, prevention and contr

    Multidrug therapy

    Dapsone

    Rifampicin

    Clofazimine

  • 7/26/2019 E learning mycobacteria 15.pdf

    42/49

    Environmental mycobacteria

  • 7/26/2019 E learning mycobacteria 15.pdf

    43/49

    Introduction

    = Atypical, opportunistic, MOTTs(mycobacterial othetuberculous), NTM(non-tuberculous mycobacteria)

    Saprophytes of soil and water

    Cause opportunistic disease

    Low virulence

    Cause disease in profound immunosuppression

  • 7/26/2019 E learning mycobacteria 15.pdf

    44/49

  • 7/26/2019 E learning mycobacteria 15.pdf

    45/49

    Clinical importance

    Most prevalent= MAC

    M.avium intracellulare

    M.avium avium

    Cause lymphadenitis and pulmonary lesions

    Disseminated disease in profound immunosuppressi

    M.ulcerans- causes Buruli ulcer

    M.xenopi- pulmonary lesions in man

    l l

  • 7/26/2019 E learning mycobacteria 15.pdf

    46/49

    Clinical importance

    M.chelonae; M.absessus; M.fortuitum; M.peregrinum

    Responsible for post-injection abscesses and wouinfections including corneal ulcers

    Opportunistic diseases caused b

  • 7/26/2019 E learning mycobacteria 15.pdf

    47/49

    Opportunistic diseases caused b

    MOTTs1. Localized lymphadenitis

    2. Skin lesions following traumatic inoculation of bact

    3. Tuberculosis-like pulmonary lesions

    4. Tuberculosis-like non-pulmonary lesions

    5. Disseminated disease

    L b di i T

  • 7/26/2019 E learning mycobacteria 15.pdf

    48/49

    Laboratory diagnosis, Treatment

    Microscopy, culture

    Resistant to many anti-TB drugs

    Rifampicin + Ethambutol- 18-24 months

    Macrolides

    Fluoroquinolones

  • 7/26/2019 E learning mycobacteria 15.pdf

    49/49